Technetium-99m-sestamibi scanning in recurrent medullary thyroid carcinoma

Journal of Nuclear Medicine

Volumn 38, Issue 2, 1997, Pages 227-230

  Learoyd, Diana L ^b   Roach, Paul J ^b   Briggs, Greg M ^b   Delbridge, Leigh W ^b   Wilmshurst, Errol G ^b   Robinson, Bruce G ^a  

^a ROYAL NORTH SHORE HOSPITAL   (Australia)

^b NONE

Author keywords

bone scan; computed tomography; medullary thyroid carcinoma; technetium 99m sestamibi

Indexed keywords

CALCITONIN; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BONE SCINTISCANNING; CALCITONIN BLOOD LEVEL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LIVER SCINTISCANNING; MALE; PRIORITY JOURNAL; RECURRENT CANCER; SOFT TISSUE CANCER; THYROID MEDULLARY CARCINOMA; TUMOR LOCALIZATION;

ADULT; AGED; BIOLOGICAL MARKERS; BONE NEOPLASMS; CALCITONIN; CARCINOMA, MEDULLARY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SENSITIVITY AND SPECIFICITY; SOFT TISSUE NEOPLASMS; TECHNETIUM TC 99M SESTAMIBI; THYROID NEOPLASMS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0031047093     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Saad MF, Ordonez NG, Rashid RK, et al. Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients. Med Baltimore 1984;63:319-342.
2. Lairmore TC, Wells SA Jr. Medullary carcinoma of the thyroid: current diagnosis and management. Semin Surg Oncol 1991;7:92-99.
3. Kallinowski F, Buhr HJ, Meybier H, Eberhardt M, Herferth C. Medullary carcinoma of the thyroid-therapeutic strategy derived from 15 years of experience. Surgery 1993;114:491-496.
4. Tisell LE, Hansson G, Jansson S, Salander H. Reoperation in the treatment of asymptomatic metastasizing medullary thyroid carcinoma. Surgery 1986;99:60-66.
5. Frank-Raue K, Raue F, Buhr HJ, Baldauf G, Lorenz D, Ziegler R. Localization of occult persisting medullary thyroid carcinoma before microsurgical reoperation: high sensitivity of selective venous catheterization. Thyroid 1992;2:113-117.
6. Hoefnagel CA, Delprat CC, Zanin D, van der Schoot JB. New radionuclide tracers for the diagnosis and therapy of medullary thyroid carcinoma. Clin Nucl Med 1988;13: 159-165.
7. Frank-Raue K, Bihl H, Dorr H, Buhr H, Ziegler R, Raue F. Somatostatin receptor imaging in persistent medullary thyroid carcinoma. Clin Endocrinol 1995;42:31-37.
8. Dorr U, Wurstlin S, Frank-Raue K, et al. Somatostatin receptor scintigraphy and magnetic resonance imaging in recurrent medullary thyroid carcinoma: a comparative study. Horm Metab Res Suppl 1993;27:48-55.
9. Lebouthillier G, Morais J, Picard M, Picard D, Chartrand R, D'Amour P. Technetium-99m-sestamibi and other agents in the detection of metastatic medullary carcinoma of the thyroid. Clin Nucl Med 1993;18:657-661.
10. Kahn JK, McGhie I, Akers MS, et al. Quantitative rotational tomography with thallium-201 and technetium-99m 2-methoxy-isobutyl-isonitrile: a direct comparison in normal individuals and patients with coronary artery disease. Circulation 1989;79: 1282-1293.
11. Billotey C, Aurengo A, Najean Y, et al. Identifying abnormal parathyroid glands in the thyroid uptake area using technetium-99m-sestamibi and factor analysis of dynamic structures. J Nucl Med 1994;35:1631-1636.
12. 99mTc-sestamibi scintigraphy as a first-line imaging procedure in the preoperative evaluation of hyperparathyroidism. Clin Endocrinol 1995;43:525-530.
13. O'Driscoll CM, Baker F, Casey MJ, Duffy GJ. Localization of recurrent medullary thyroid carcinoma with technetium-99m-methoxyisobutylnitrile scintigraphy: a case report. J Nucl Med 1991;32:2281-2283.
14. Hassan IM, Sahweil A, Constantinides C, et al. Uptake and kinetics of technetium-99m hexakis 2 methoxy isobutyl isonitrile in benign and malignant lesions of the lungs. Clin Nucl Med 1989;14:333-340.
15. 99mTc-methoxyisobutylisonitrile SPECT. Nucl Med Commun 1993;14:42-46.
16. Ziegels P, Nocaudie M, Huglo D, et al. Comparison of technetium-99m methoxyisobutylisonitrile and gallium-67 citrate scanning in the assessment of lymphomas. Eur J Nucl Med 1995;22:126-131.
17. Beller GA, Watson DD. Physiological basis of myocardial perfusion imaging with technetium-99m agents. Semin Nucl Med 1991;21:173-181.
18. 99mTc-MIBI SPECT [Abstract]. J Nucl Med 1987;28:562.
19. 99mTc-MIBI whole body scintigraphy: a case report. Kaku Igaku 1994;31:1243-1248.
20. Vattimo A, Bertelli P, Cintorino M, Burroni L, Volterrani D, Vella A. Identification of Hurthle cell tumor by single-injection, double-phase SCI technetium-99m-sestamibi. J Nucl Med 1995;36:778-782.
21. Rubens MB. Chest trauma: the postoperative chest: intensive care: radiation. In: Sutton D, ed. A textbook of radiology and imaging, 4th ed. London: Churchill Livingstone; 1987:518-519.